Treatment

DIPHENHYDRAMINE , FAMOTIDINE , PEGENZILEUKIN, TOCILIZUMAB , ONDANSETRON , DEXAMETHASONE , PARACETAMOL clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingPhase I and Phase II (Integrated)- Other
An open-label, multicenter Phase 1/2 dose escalation and expansion study of THOR-707 as a single agent and as a combination therapy in adult subjects with advanced or metastatic solid tumors
This study is testing a new medicine, THOR-707, for people with advanced cancer. It aims to find the safest and most effective dose, and see how well it works alone or with other treatments to shrink tumours and improve health.
For: Cancer
Spain